How Does BAV Affect Aortic Stenosis and Aorta Monitoring?
At a Glance
A bicuspid aortic valve can lead to aortic stenosis at a younger age and raises the risk of enlargement of the aortic root or ascending aorta. Lifelong imaging tracks both, while surgery decisions depend on symptoms, heart function, aortic size, growth, and anatomy.
In this answer
5 sections
A bicuspid aortic valve (BAV) can alter the trajectory of aortic stenosis, sometimes causing the valve to narrow more rapidly. On average across the population, people with a bicuspid valve who develop severe narrowing may require treatment 10 to 20 years earlier than those with standard valves, though individual experiences vary greatly [1]. In addition to the valve itself, having a BAV increases your risk of developing an enlarged aorta, known as an aneurysm [2]. Because of this, your care team will monitor both the function of your valve and the size of your aorta over your lifetime [3].
The Two-Leaflet Anatomy and Earlier Narrowing
A normal aortic valve has three flaps (leaflets) that open and close to regulate blood flow. A bicuspid valve has only two [4].
Because a two-leaflet valve manages the same blood flow with fewer flaps, it experiences elevated mechanical stress [4]. This extra wear-and-tear can lead to premature calcification, which is the buildup of calcium deposits on the valve [5].
As calcium accumulates, the valve can become stiff and narrowed (stenosis). While some people with BAV never develop severe stenosis, those who do often experience it at a younger age than people with three-leaflet valves [1]. Once the valve is noticeably narrowed, the rate at which the stenosis worsens is generally similar to three-leaflet valves, but it begins sooner [6].
BAV and Your Aorta (Aortopathy)
BAV is associated with an increased risk of aortopathy, an underlying disease of the aorta’s tissue [2]. A substantial minority of patients with BAV will develop dilation (enlargement) of the aortic root or the ascending aorta, which is the portion of the main blood vessel rising directly out of the heart [7]. Hearing about aneurysm risk can be alarming, but an enlarged aorta does not mean a tear is inevitable; surveillance is designed to detect changes early so you can be treated safely.
A baseline transthoracic echocardiogram (TTE) (an ultrasound of the heart) is essential for everyone with BAV to assess the valve and measure the visible aorta. If the aorta reaches 4.0 cm in diameter, this is a common guideline threshold for establishing regular, lifelong imaging surveillance [3]. The exact frequency of your scans will be personalized based on your measurements and growth rate.
If the ultrasound cannot clearly see the upper parts of your ascending aorta, your doctor will likely order a CT scan or cardiac MRI [8]. Because different imaging machines measure size slightly differently, it is best to use the same type of scan consistently when tracking growth over time [9].
Day-to-day management of aortopathy also involves careful blood pressure control. You should discuss exercise guidelines—especially regarding heavy lifting or straining—and any plans for pregnancy with your cardiologist, as these can affect the stress on your aorta [10].
When is Surgery Recommended?
Valve surgery is typically discussed when your stenosis becomes severe and you develop symptoms like worsening shortness of breath, chest tightness, or dizziness. However, intervention may also be recommended even if you have no obvious symptoms, provided tests show your heart’s pumping function is declining or the stenosis is extremely severe [11].
For the aorta, the decision to operate is highly personalized and depends on your body size, family history, and where the measurement is taken. Guidelines suggest considering preventative surgery at the following thresholds:
- 5.5 cm: The general threshold for preventative repair of the aorta in most BAV patients [12].
- 5.0 cm: Surgery may be considered at this smaller size if you have specific risk factors, a family history of aortic issues, or if you are being treated at an experienced, specialized aortic center [13][14].
- 4.5 cm: If you are already undergoing open-heart surgery to replace your aortic valve, it is generally reasonable for the surgeon to replace the enlarged aorta at the same time if it is 4.5 cm or larger [15][16].
Rapid growth of the aorta—such as increasing more than 0.5 cm in a single year, or 0.3 cm per year over two consecutive years—will also prompt your care team to consider earlier surgery [14].
When to Seek Immediate Care: Aortic disease requires attention to new or sudden symptoms. Call emergency services (such as 911) immediately if you experience sudden, severe, or “tearing” pain in your chest, back, or abdomen, sudden fainting, new neurologic symptoms, or sudden severe breathlessness [15]. If you experience worsening shortness of breath or chest pain during physical activity, contact your doctor promptly, as this can signal severe valve disease.
Choosing Between TAVR and SAVR
When it is time to replace the valve, patients consider either SAVR (Surgical Aortic Valve Replacement, an open-heart procedure) or TAVR (Transcatheter Aortic Valve Replacement, a minimally invasive procedure). Having a bicuspid valve makes this choice highly individualized.
- Treating the aorta simultaneously: TAVR does not fix an enlarged aorta. If your aorta requires repair, SAVR allows the surgeon to replace both the failing valve and the enlarged ascending aorta in a single operation [17].
- Valve shape and calcium: BAVs frequently feature a raphe (a fused ridge of extra tissue) and very heavy, uneven calcium buildup [18]. This asymmetric shape can prevent a TAVR valve from expanding fully, increasing the risk of blood leaking around the edges or causing injury to the root [19][20]. Pre-procedure CT scans are heavily relied upon to evaluate this risk.
- Age, durability, and valve type: Because BAV patients often need surgery at a younger age, long-term durability is a primary concern. During SAVR, you can choose between a mechanical valve (which is highly durable but requires lifelong blood thinners) or a tissue valve (which does not require blood thinners but may wear out over time) [21].
While SAVR is common for younger patients or those needing aorta repair, TAVR is often a reasonable option for older patients, those with high surgical risks, or those whose bicuspid anatomy is highly favorable for the procedure [22][21].
The Importance of Family Screening
Bicuspid aortic valves and associated aortic enlargement run in families. If you have a BAV, your first-degree relatives (parents, siblings, and children) have a significantly higher risk of having a bicuspid valve or developing an aortic aneurysm [23][24].
Medical guidelines strongly recommend that all first-degree relatives undergo an echocardiogram to check their valve anatomy and measure their aorta [23]. It is very important to know that relatives can develop a dangerous enlargement of their aorta even if their screening shows they have a perfectly normal, three-leaflet valve [25]. While a normal initial scan is reassuring, relatives should discuss with their doctors whether they need future surveillance, particularly if there is a strong family history of aortic disease.
Common questions in this guide
Why can a bicuspid aortic valve cause aortic stenosis earlier?
Why does bicuspid aortic valve require monitoring of the ascending aorta?
What imaging tests are used to monitor a bicuspid aortic valve and aorta?
At what aortic size might surgery be considered with BAV?
Is TAVR or SAVR better for someone with a bicuspid aortic valve?
Should my parents, siblings, or children be screened for BAV?
What symptoms require emergency care with BAV or aortic disease?
One line in your results can change your plan.
For a bicuspid valve, a measured aortic size can help decide whether lifelong imaging surveillance is recommended. We check your results against the latest research to help you prepare for what’s next.
Related questions
Show more
Get notified when new evidence is published on aortic valve stenosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (25)
- 1
Development of a Polymeric TAVR Device Tailored to Bicuspid Aortic Valve Patients Using In Silico Design Optimization and Evaluation.
Baylous K, Helbock R, Kovarovic B, et al.
Annals of biomedical engineering 2025; doi:10.1007/s10439-025-03889-7.
PMID: 41264159 - 2
The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: Full online-only version.
Borger MA, Fedak PWM, Stephens EH, et al.
The Journal of thoracic and cardiovascular surgery 2018; (156(2)):e41-e74 doi:10.1016/j.jtcvs.2018.02.115.
PMID: 30011777 - 3
Giant Thoracic Aneurysm Following Valve Replacement for Bicuspid Aortic Valve.
Tran C, Ul Haq E, Nguyen N, Omar B
Reviews in cardiovascular medicine 2015; (16(4)):255-60 doi:10.3909/ricm0786.
PMID: 26827748 - 4
The role of stress concentration in calcified bicuspid aortic valve.
Qin T, Caballero A, Mao W, et al.
Journal of the Royal Society, Interface 2020; (17(167)):20190893 doi:10.1098/rsif.2019.0893.
PMID: 32517630 - 5
Molecular and Mechanical Mechanisms of Calcification Pathology Induced by Bicuspid Aortic Valve Abnormalities.
Kazik HB, Kandail HS, LaDisa JF, Lincoln J
Frontiers in cardiovascular medicine 2021; (8()):677977 doi:10.3389/fcvm.2021.677977.
PMID: 34124206 - 6
Prognostic Implications of Bicuspid and Tricuspid Aortic Valve Phenotype on Progression of Moderate Aortic Stenosis and Ascending Aorta Dilatation.
Chew NWS, Phua K, Ho YJ, et al.
The American journal of cardiology 2021; (161()):76-83 doi:10.1016/j.amjcard.2021.08.050.
PMID: 34627597 - 7
Characteristics and long-term outcomes of contemporary patients with bicuspid aortic valves.
Masri A, Kalahasti V, Alkharabsheh S, et al.
The Journal of thoracic and cardiovascular surgery 2016; (151(6)):1650-1659.e1.
PMID: 26825434 - 8
Multimodality imaging in bicuspid aortic valve.
Galian-Gay L, Rodríguez-Palomares J, Guala A, et al.
Progress in cardiovascular diseases 2020; (63(4)):442-451 doi:10.1016/j.pcad.2020.06.003.
PMID: 32531300 - 9
Imaging-Based Phenotyping in Bicuspid Aortic Valve and Associated Aortopathy: A Retrospective Single-Center Study.
Šarkinas L, Valevičienė NR, Glaveckaitė S, Palionis D
Medicina (Kaunas, Lithuania) 2026; (62(4)) doi:10.3390/medicina62040790.
PMID: 42075661 - 10
Navigating the challenges of bicuspid aortic valve-aortopathy.
Kanagala SG, Sawhney A, Parikh K, et al.
Global cardiology science & practice 2023; (2023(4)):e202327 doi:10.21542/gcsp.2023.27.
PMID: 38404628 - 11
Cardiac damage stages and prognosis in patients with bicuspid versus tricuspid aortic valve: insights from the CURRENT AS Registry-2.
Saitoh W, Taniguchi T, Takeji Y, et al.
Cardiovascular intervention and therapeutics 2026; (41(3)):705-716 doi:10.1007/s12928-026-01262-6.
PMID: 41774425 - 12
Surgical threshold for bicuspid aortic valve aneurysm: a case for individual decision-making.
Adamo L, Braverman AC
Heart (British Cardiac Society) 2015; (101(17)):1361-7 doi:10.1136/heartjnl-2014-306601.
PMID: 26076937 - 13
Aortic Dissection in Patients With Bicuspid Aortic Valve-Associated Aneurysms.
Wojnarski CM, Svensson LG, Roselli EE, et al.
The Annals of thoracic surgery 2015; (100(5)):1666-73; discussion 1673-4.
PMID: 26209494 - 14
Bicuspid aortic valve associated aortopathy: 2022 guideline update.
Verma R, Cohen G, Colbert J, Fedak PWM
Current opinion in cardiology 2023; (38(2)):61-67 doi:10.1097/HCO.0000000000001020.
PMID: 36718616 - 15
Surgical management of the aorta in BAV patients.
Etz CD, Haunschild J, Girdauskas E, et al.
Progress in cardiovascular diseases 2020; (63(4)):475-481 doi:10.1016/j.pcad.2020.06.013.
PMID: 32640281 - 16
The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: Executive summary.
Borger MA, Fedak PWM, Stephens EH, et al.
The Journal of thoracic and cardiovascular surgery 2018; (156(2)):473-480 doi:10.1016/j.jtcvs.2017.10.161.
PMID: 30011756 - 17
Management of bicuspid aortic valve disease in the transcatheter aortic valve implantation era.
Jahangiri M, Prendergast B
Heart (British Cardiac Society) 2024; (110(22)):1291-1297 doi:10.1136/heartjnl-2024-324054.
PMID: 39117383 - 18
Transcatheter aortic valve replacement in bicuspid aortic valve stenosis.
Yoon SH, Webb JG, Leon MB, Makkar R
Progress in cardiovascular diseases 2020; (63(4)):482-487 doi:10.1016/j.pcad.2020.06.007.
PMID: 32592707 - 19
Bicuspid Aortic Valve Morphology and Outcomes After Transcatheter Aortic Valve Replacement.
Yoon SH, Kim WK, Dhoble A, et al.
Journal of the American College of Cardiology 2020; (76(9)):1018-1030 doi:10.1016/j.jacc.2020.07.005.
PMID: 32854836 - 20
Advances in Transcatheter Aortic Valve Therapy in Bicuspid Aortic Valve Disease: Insight into Patient Selection, Management, and Future Directions.
Cammalleri V, Ussia G, Lusini M, et al.
Surgical technology international 2021; (39()):303-307 doi:10.52198/21.STI.39.CV1468.
PMID: 34749422 - 21
International Age and Use Criteria for Transcatheter and Surgical Aortic Valve Replacement.
Sharma R, Srivats S, Ata F, Shuhaiber J
Reviews in cardiovascular medicine 2026; (27(6)):49368 doi:10.31083/RCM49368.
PMID: 42416597 - 22
Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Bicuspid Aortic Valve Stenosis-We Need a Well-Designed Randomized Control Trial.
Grubb KJ, Tom SK, Xie J, et al.
Journal of clinical medicine 2024; (13(21)) doi:10.3390/jcm13216565.
PMID: 39518704 - 23
First-Degree Relatives Screening of Patients with Bicuspid Aortic Valve: Effectiveness and Feasibility in Pediatric Cardiology Daily Practice.
Massardier C, Desroches F, Singbo N, et al.
Pediatric cardiology 2020; (41(8)):1645-1650 doi:10.1007/s00246-020-02423-x.
PMID: 32851436 - 24
Familial Associations of Prevalence and Cause-Specific Mortality for Thoracic Aortic Disease and Bicuspid Aortic Valve in a Large-Population Database.
Glotzbach JP, Hanson HA, Tonna JE, et al.
Circulation 2023; (148(8)):637-647 doi:10.1161/CIRCULATIONAHA.122.060439.
PMID: 37317837 - 25
Family screening for bicuspid aortic valve and aortic dilatation: a meta-analysis.
Bray JJH, Freer R, Pitcher A, Kharbanda R
European heart journal 2023; (44(33)):3152-3164 doi:10.1093/eurheartj/ehad320.
PMID: 37288540
This page is for informational purposes only and does not constitute medical advice. Your cardiologist and cardiac surgeon should interpret your valve and aorta measurements and advise you about imaging, activity, pregnancy, and treatment.